Science ❯ Biology ❯ Genetics ❯ Gene Therapy

Clinical Trials

Eli Lilly to Buy Kelonia for Up to $7 Billion to Gain In‑Vivo CAR‑T Platform

The move signals a push to broaden cancer care with simpler, one‑time treatments made inside the body.

Gene Therapy Slows Huntington’s Progression by 75% in Early Trial, uniQure Says